Literature DB >> 21725309

Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers.

Daiki Miki1, Hidenori Ochi, C Nelson Hayes, Hiromi Abe, Tadahiko Yoshima, Hiroshi Aikata, Kenji Ikeda, Hiromitsu Kumada, Joji Toyota, Takashi Morizono, Tatsuhiko Tsunoda, Michiaki Kubo, Yusuke Nakamura, Naoyuki Kamatani, Kazuaki Chayama.   

Abstract

Chronic viral hepatitis is the most important risk factor for progression to hepatocellular carcinoma (HCC). To identify genetic risk factors for progression to HCC in individuals with chronic hepatitis C virus (HCV), we analyzed 467,538 SNPs in 212 Japanese individuals with chronic HCV with HCC and 765 individuals with chronic HCV without HCC. We identified one intronic SNP in the DEPDC5 locus on chromosome 22 associated with HCC risk and confirmed the association using an independent case-control population (710 cases and 1,625 controls). The association was highly significant when we analyzed the stages separately as well as together (rs1012068, P(combined) = 1.27 × 10(-13), odds ratio = 1.75). The significance level of the association further increased after adjustment for gender, age and platelet count (P = 1.35 × 10(-14), odds ratio = 1.96). Our findings suggest that common variants within the DEPDC5 locus affect susceptibility to HCC in Japanese individuals with chronic HCV infection.

Entities:  

Mesh:

Year:  2011        PMID: 21725309     DOI: 10.1038/ng.876

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  28 in total

1.  A high-throughput SNP typing system for genome-wide association studies.

Authors:  Y Ohnishi; T Tanaka; K Ozaki; R Yamada; H Suzuki; Y Nakamura
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

2.  A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B.

Authors:  Toshimasa Yamauchi; Kazuo Hara; Shiro Maeda; Kazuki Yasuda; Atsushi Takahashi; Momoko Horikoshi; Masahiro Nakamura; Hayato Fujita; Niels Grarup; Stephane Cauchi; Daniel P K Ng; Ronald C W Ma; Tatsuhiko Tsunoda; Michiaki Kubo; Hirotaka Watada; Hiroshi Maegawa; Miki Okada-Iwabu; Masato Iwabu; Nobuhiro Shojima; Hyoung Doo Shin; Gitte Andersen; Daniel R Witte; Torben Jørgensen; Torsten Lauritzen; Annelli Sandbæk; Torben Hansen; Toshihiko Ohshige; Shintaro Omori; Ikuo Saito; Kohei Kaku; Hiroshi Hirose; Wing-Yee So; Delphine Beury; Juliana C N Chan; Kyong Soo Park; E Shyong Tai; Chikako Ito; Yasushi Tanaka; Atsunori Kashiwagi; Ryuzo Kawamori; Masato Kasuga; Philippe Froguel; Oluf Pedersen; Naoyuki Kamatani; Yusuke Nakamura; Takashi Kadowaki
Journal:  Nat Genet       Date:  2010-09-05       Impact factor: 38.330

3.  Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups.

Authors:  T Poynard; P Bedossa
Journal:  J Viral Hepat       Date:  1997-05       Impact factor: 3.728

4.  A simple approximation for calculating sample sizes for detecting linear trend in proportions.

Authors:  J M Nam
Journal:  Biometrics       Date:  1987-09       Impact factor: 2.571

5.  Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells.

Authors:  Yosuke Harada; Mitsugu Kanehira; Yoshiko Fujisawa; Ryo Takata; Taro Shuin; Tsuneharu Miki; Tomoaki Fujioka; Yusuke Nakamura; Toyomasa Katagiri
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

6.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

Authors:  Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

7.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

8.  Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.

Authors:  Shunsuke Ura; Masao Honda; Taro Yamashita; Teruyuki Ueda; Hajime Takatori; Ryuhei Nishino; Hajime Sunakozaka; Yoshio Sakai; Katsuhisa Horimoto; Shuichi Kaneko
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

9.  Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Authors:  Tania Mara Welzel; Timothy R Morgan; Herbert L Bonkovsky; Deepa Naishadham; Ruth M Pfeiffer; Elizabeth C Wright; Amy A Hutchinson; Andrew T Crenshaw; Arman Bashirova; Mary Carrington; Myhanh Dotrang; Richard K Sterling; Karen L Lindsay; Robert J Fontana; William M Lee; Adrian M Di Bisceglie; Marc G Ghany; David R Gretch; Stephen J Chanock; Raymond T Chung; Thomas R O'Brien
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

10.  Conformational stability studies of the pleckstrin DEP domain: definition of the domain boundaries.

Authors:  A Kharrat; S Millevoi; E Baraldi; C P Ponting; P Bork; A Pastore
Journal:  Biochim Biophys Acta       Date:  1998-06-11
View more
  62 in total

Review 1.  How do persistent infections with hepatitis C virus cause liver cancer?

Authors:  Jonathan K Mitchell; Stanley M Lemon; David R McGivern
Journal:  Curr Opin Virol       Date:  2015-09-29       Impact factor: 7.090

2.  HLA class II associated with outcomes of hepatitis B and C infections.

Authors:  Akihiro Tamori; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

3.  Genome-wide association studies: inherent limitations and future challenges.

Authors:  Yan Du; Jiaxin Xie; Wenjun Chang; Yifang Han; Guangwen Cao
Journal:  Front Med       Date:  2012-11-03       Impact factor: 4.592

Review 4.  Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.

Authors:  Yujin Hoshida; Bryan C Fuchs; Kenneth K Tanabe
Journal:  Curr Cancer Drug Targets       Date:  2012-11-01       Impact factor: 3.428

Review 5.  Mechanisms of hepatocarcinogenesis in chronic hepatitis C.

Authors:  Jonathan K Mitchell; David R McGivern
Journal:  Hepat Oncol       Date:  2014-09-09

6.  Association between TGF-β1 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.

Authors:  Ying Guo; Chunbao Zang; Yajun Li; Li Yuan; Qingjun Liu; Lingyan Zhang; Shaolin Li
Journal:  Genet Test Mol Biomarkers       Date:  2013-09-09

Review 7.  Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.

Authors:  Paola Dongiovanni; Stefano Romeo; Luca Valenti
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 8.  Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.

Authors:  Cristina Della Corte; Alessio Aghemo; Massimo Colombo
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

9.  Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.

Authors:  Etienne Patin; Zoltán Kutalik; Julien Guergnon; Stéphanie Bibert; Bertrand Nalpas; Emmanuelle Jouanguy; Mona Munteanu; Laurence Bousquet; Laurent Argiro; Philippe Halfon; Anne Boland; Beat Müllhaupt; David Semela; Jean-François Dufour; Markus H Heim; Darius Moradpour; Andreas Cerny; Raffaele Malinverni; Hans Hirsch; Gladys Martinetti; Vijayaprakash Suppiah; Graeme Stewart; David R Booth; Jacob George; Jean-Laurent Casanova; Christian Bréchot; Charles M Rice; Andrew H Talal; Ira M Jacobson; Marc Bourlière; Ioannis Theodorou; Thierry Poynard; Francesco Negro; Stanislas Pol; Pierre-Yves Bochud; Laurent Abel
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

Review 10.  Multiple amino acid sensing inputs to mTORC1.

Authors:  Mitsugu Shimobayashi; Michael N Hall
Journal:  Cell Res       Date:  2015-12-11       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.